DAVID PLATT - 14 Sep 2023 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Issuer symbol
BIXT
Transactions as of
14 Sep 2023
Transactions value $
$786,340
Form type
4
Filing time
15 Sep 2023, 19:21:37 UTC
Previous filing
24 Aug 2023
Next filing
16 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common Award $786K +5.82M +56.72% $0.14 16.1M 14 Sep 2023 by NDPD Pharma, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.